Corporate Investor

Updated:

Dong-A Socio Holdings

Dong-A Socio Holdings was established in 1949. Kang Joong-hee founded the predecessor Dong-A Pharmaceutical in 1932. His son Kang Shin-ho later served as...

Dong-A Socio Holdings logo

Dong-A Socio Holdings

Dong-A Socio Holdings was established in 1949. Kang Joong-hee founded the predecessor Dong-A Pharmaceutical in 1932. His son Kang Shin-ho later served as honorary chairman and developed the Bacchus beverage brand. Kang Jung-seok, fourth son of Kang Shin-ho, holds the chairman role and is the largest individual shareholder. The firm maintains holdings in pharmaceuticals, biosimilars, medical services, beverages, logistics, IT, real estate and materials. It operates manufacturing sites including the Songdo Pharmaceutical Plant and Banwol Factory. Geographic reach centers on South Korea with additional facilities in Gyeonggi-do and Gyeongsangbuk-do. Joint-venture activity includes the long-standing partnership with Otsuka Holdings in Dong-A Otsuka. National Pension Service of Korea appears among major institutional shareholders. Additional properties encompass the Sangju and Yongin human-resources centers plus the Anseong Second Center. The firm joined the UN Global Compact in 2020 and participates in the Business Integrity Society. Philanthropic activity runs through the Sooseok Cultural Foundation.

General information

Firm type

Corporate Investor

Year founded

1949

AUM

Undisclosed

Location

Region

Asia

Country

South Korea

City

Seoul

Corporate office

64 Cheonho-daero, Dongdaemun-gu, Seoul, Republic of Korea

Principals

Kang Joong-hee

Founder

Kang Shin-ho

Honorary Chairman

Kang Jung-seok

Chairman

Sector focus

PharmaceuticalsBiosimilarsBeverageLogisticsReal EstateMaterials

Frequently asked questions

Who runs investment decisions at Dong-A Socio Holdings?

Kang Jung-seok serves as chairman and largest individual shareholder. Decisions align with the operating businesses controlled by the holding company.

How is Dong-A Socio Holdings related to Dong-A Pharmaceutical?

Dong-A Socio Holdings was established in 1949 as the corporate parent structure above the pharmaceutical operations founded by Kang Joong-hee in 1932.

Does Dong-A Socio Holdings participate in external fund commitments?

Activity centers on direct ownership of operating companies and manufacturing assets. No external fund commitments are disclosed in available records.

Which external partners appear in Dong-A Socio Holdings investments?

Otsuka Holdings maintains a joint venture in Dong-A Otsuka. Glaxo Group Limited holds a strategic position in Dong-A ST. National Pension Service of Korea is a major institutional shareholder.

Where does the underlying wealth originate?

Wealth traces to the pharmaceutical business started by Kang Joong-hee in 1932 and expanded under subsequent family leadership into beverages and other sectors.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Seoul Corporate Investor profiles